Back to results
US 2006/0142379 A1Published application
Use of AP-1 activators to treat glaucoma and ocular hypertension
OwnerDebra Shade, Iok-Hou Pang +1inventors
InventorsDebra Shade, Iok-Hou Pang, Abbot Clark
Life of this patent
Estimating the term…
Abstract
Compositions comprising AP-1 activators and methods of use for treating glaucoma and ocular hypertension are disclosed.
Claims8
A topical composition for treating glaucoma or ocular hypertension comprising an AP-1 Activator and a pharmaceutically acceptable vehicle.
A method for treating glaucoma or ocular hypertension which comprises administering to a mammal a composition comprising an AP-1 Activator and a pharmaceutically acceptable vehicle.
Dependencies are inferred from the claim text.